The current standard of care calls for EGFR sequencing in all advanced-stage (stage IV and recurrence) patients with NSCLC of all histological subtypes, except for squamous cell carcinoma [7, 8]. The gene discussed is EGFR; the disease is squamous cell carcinoma.